Future research should focus on the role of IL-10 in relation to exhausted CD8+ T cells in non-small cell lung cancer, as well as the key factors influencing this dynamic, to improve the efficacy of lung cancer immunotherapies. The gene discussed is CD8A; the disease is lung cancer.